Background: Refractory congestive heart failure (RCHF) is associated with a high mortality rate and is a major contributor to hospital admissions. Peritoneal dialysis (PD) is an option to control volume overload and perhaps improve outcomes in this challenging patient population. The aim of this systematic review is to describe the relative risk-benefit ratio based on data reported regarding the use of PD in RCHF. This study was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. An electronic search of PubMed, Embase, and the Cochrane Library was performed to identify relevant studies published from January 1951 to February 2014. Eligible studies selected were prospective or retrospective adult population studies on PD in the setting of RCHF. The following clinical outcomes were used to assess PD therapy: (1) hospitalization rates; (2) heart function; (3) renal function; (4) fluid overload, and (5) adverse clinical outcomes. Summary: Of 864 citations, we excluded 843 citations and included 21 studies (n = 673 patients). After PD, hospitalization days declined significantly (p = 0.0001), and heart function improved significantly (left ventricular ejection fraction: p = 0.0013; New York Heart Association classification: p = 0.0000). There were no statistically significant differences in glomerular filtration rate after PD treatment in non-chronic kidney disease stage 5D patients (p = 0.1065). Among patients treated with PD, body weight decreased significantly (p = 0.0006). The yearly average peritonitis rate was 14.5%, and the average yearly mortality was 20.3%. Key Messages: This systematic review suggests that PD may be an effective and safe therapeutic tool for patients with RCHF.

Keywords:
Extracorporeal ultrafiltration, Heart function, Glomerular filtration rate, Hospitalization days
1.
Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, Konstam MA, Mancini DM, Rahko PS, Silver MA, Stevenson LW, Yancy CW: 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009;119:1977-2016.
2.
Fonarow GC; ADHERE Scientific Advisory Committee: The Acute Decompensated Heart Failure National Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure. Rev Cardiovasc Med 2003;4:S21-S30.
3.
Schrier RW: Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor? J Am Coll Cardiol 2006;47:1-8.
4.
Ronco C, Haapio M, House AA, Anavekar N, Bellomo R: Cardiorenal syndrome. J Am Coll Cardiol 2008;52:1527-1539.
5.
Bart BA, Goldsmith SR, Lee KL, Givertz MM, O'Connor CM, Bull DA, Redfield MM, Deswal A, Rouleau JL, LeWinter MM, Ofili EO, Stevenson LW, Semigran MJ, Felker GM, Chen HH, Hernandez AF, Anstrom KJ, McNulty SE, Velazquez EJ, Ibarra JC, Mascette AM, Braunwald E; for the Heart Failure Clinical Research Network: Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med 2012;367:2296-2304.
6.
Costanzo MR, Saltzberg M, O'Sullivan J, Sobotka P: Early ultrafiltration in patients with decompensate heart failure and diuretic resistance. J Am Coll Cardiol 2005;46:2047-2051.
7.
Ruhi Ç, Koçak H, Yavuz A, Süleymanlar G, Ersoy FF: Use of peritoneal ultrafiltration in the elderly refractory congestive heart failure patients. Int Urol Nephrol 2012;44:963-969.
8.
Kunin M, Arad M, Dinour D, Freimark D, Holtzman EJ: Peritoneal dialysis in patients with refractory congestive heart failure: potential prognostic factors. Blood Purif 2013;35:285-294.
9.
Rizkallah J, Sood MM, Reslerova M, Cordova F, Malik A, Sathianathan C, Estrella-Holder E, Zieroth S: Reduced hospitalizations in severe, refractory congestive heart failure with peritoneal dialysis: a consecutive case series. Clin Nephrol 2013;80:334-341.
10.
Bertoli SV, Musetti C, Ciurlino D, Basile C, Galli E, Gambaro G, Iadarola G, Guastoni C, Carlini A, Fasciolo F, Borzumati M, Gallieni M, Stefania F: Peritoneal ultrafiltration in refractory heart failure: a cohort study. Perit Dial Int 2014;34:64-70.
11.
Benhamou E, Albou A, Griguer P, Pons J: New observations on irreducible edema in cardiacs treated successfully by peritoneal dialysis with glucose; diagnostic and therapeutic value of osmotic pressure in cardiac. Bull Mem Soc Med Hop Paris 1951;67:741-751.
12.
Sánchez JE, Rodríguez C, González I, Fernández-Viña A, Núñez M, Peláez B: Analysis of the advantages of peritoneal dialysis in the treatment of chronic refractory heart failure. Nefrologia 2010;30:487-489.
13.
Davenport A: Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002-2003. Perit Dial Int 2009;29:297-302.
14.
Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009;62:1006-1012.
15.
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL: 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2013;128:1810-1852.
16.
Sánchez JE, Ortega T, Rodríguez C, Díaz-Molina B, Martín M, Garcia-Cueto C, Vidau P, Gago E, Ortega F: Efficacy of peritoneal ultrafiltration in the treatment of refractory congestive heart failure. Nephrol Dial Transplant 2010;25:605-610.
17.
Gotloib L, Fudin R, Yakubovich M, Vienken J: Peritoneal dialysis in refractory end-stage congestive heart failure: a challenge facing a no-win situation. Nephrol Dial Transplant 2005;20:vii32-vii36.
18.
Stegmayr BG, Banga R, Lundberg L, Wikdahl AM, Plum-Wirell M: PD treatment for severe congestive heart failure. Perit Dial Int 1996;16:S231-S235.
19.
König PS, Lhotta K, Kronenberg F, Joannidis M, Herold M: CAPD: a successful treatment in patients suffering from therapy-resistant congestive heart failure. Adv Perit Dial 1991;7:97-101.
20.
Núñez J, González M, Miñana G, Garcia-Ramón R, Sanchis J, Bodí V, Núñez E, Puchades MJ, Palau P, Merlos P, Mascarell B, Miguel A: Continuous ambulatory peritoneal dialysis and clinical outcomes in patients with refractory congestive heart failure. Rev Esp Cardiol (Engl Ed) 2012;65:986-995.
21.
Takane H, Nakamoto H, Arima H, Shoda J, Moriwaki K, Ikeda N, Kobayashi K, Kanno Y, Sugahara S, Okada H, Suzuki H: Continuous ambulatory peritoneal dialysis is effective for patients with severe congestive heart failure. Adv Perit Dial 2006;22:141-146.
22.
Ryckelynck J-P, Lobbedez T, Valette B, Le Goff C, Mazouz O, Levaltier B, Potier JC, Hurault de Ligny B: Peritoneal ultrafiltration and treatment-resistant heart failure. Nephrol Dial Transplant 1998;13:56-59.
23.
Hébert MJ, Falardeau M, Pichette V, Houde M, Nolin L, Cardinal J, Ouimet D: Continuous ambulatory peritoneal dialysis for patients with severe left ventricular systolic dysfunction and end-stage renal disease. Am J Kidney Dis 1995;25:761-768.
24.
Sotirakopoulos NG, Kalogiannidou IM, Tersi ME, Mavromatidis KS: Peritoneal dialysis for patients suffering from severe heart failure. Clin Nephrol 2011;76:124-129.
25.
Nakayama M, Nakano H, Nakayama M: Novel therapeutic option for refractory heart failure in elderly patients with chronic kidney disease by incremental peritoneal dialysis. J Cardiol 2010;55:49-54.
26.
Cnossen TT, Kooman JP, Konings CJ, Uszko-Lencer NH, Leunissen KM, van der Sande FM: Peritoneal dialysis in patients with primary cardiac failure complicated by renal failure. Blood Purif 2010;30:146-152.
27.
Cnossen TT, Kooman JP, Krepel HP, Konings CJ, Uszko-Lencer NH, Leunissen KM, van der Sande FM: Prospective study on clinical effects of renal replacement therapy in treatment-resistant congestive heart failure. Nephrol Dial Transplant 2012;27:2794-2799.
28.
Aggarwal HK, Sumit, Nand N, Sen J, Singh M: Evaluation of role of acute intermittent peritoneal dialysis in resistant congestive heart failure. J Assoc Physicians India 2002;50:1115-1119.
29.
Bilora F, Petrobelli F, Boccioletti V, Pomerri F: Treatment of heart failure and ascites with ultrafiltration in patients with intractable alcoholic cardiomyopathy. Panminerva Med 2002;44:23-25.
30.
Sheppard R, Panyon J, Pohwani AL, Kapoor A, Macgowan G, McNamara D, Mathier M, Johnston JR, Murali S: Intermittent outpatient ultrafiltration for the treatment of severe refractory congestive heart failure. J Card Fail 2004;10:380-383.
31.
Neumann T, Biermann J, Erbel R, Neumann A, Wasem J, Ertl G, Dietz R: Heart failure: the commonest reason for hospital admission in Germany: medical and economic perspectives. Dtsch Arztebl Int 2009;106:269-275.
32.
Hall MJ, Levant S, DeFrances CJ: Hospitalization for congestive heart failure: United States, 2000-2010. Data from National Hospital Discharge Survey, 2000-2010. National Center for Health Statistics (NCHS) Data Brief, No 108, October 2012.
33.
Martínez-Sellés M, García Robles JA, Prieto L, Serrano JA, Muñoz R, Frades E, Almendral J: Annual rates of admission and seasonal variations in hospitalizations for heart failure. Eur J Heart Fail 2002;4:779-786.
34.
Klein L, O'Connor CM, Gattis WA, Zampino M, de Luca L, Vitarelli A, Fedele F, Gheorghiade M: Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations. Am J Cardiol 2003;91:18F-40F.
35.
Nohria A, Lewis E, Stevenson LW: Medical management of advanced heart failure. JAMA 2002;287:628-640.
36.
Jessup M, Brozena S: Heart failure. N Engl J Med 2003;348:2007-2018.
37.
Mcligeyo SO: Intermittent peritoneal dialysis in the management of refractory heart failure. Cent Afr J Med 1992;38:421-424.
38.
Tormey V, Conlon PJ, Farrell J, Horgan J, Walshe JJ: Long-term successful management of refractory congestive cardiac failure by intermittent ambulatory peritoneal ultrafiltration. Q J Med 1996;89:681-683.
39.
Kazory A, Ross EA: Contemporary trends in the pharmacological and extracorporeal management of heart failure: a nephrologic perspective. Circulation 2008;117:975-983.
40.
Cnossen N, Kooman JP, Konings CJ, van Dantzig JM, van der Sande FM, Leunissen K: Peritoneal dialysis in patients with congestive heart failure. Nephrol Dial Transplant 2006;21:ii63-ii66.
41.
Ellison DH: Diuretic therapy and resistance in congestive heart failure. Cardiology 2001;96:132-143.
42.
Wang AY: The ‘heart' of peritoneal dialysis. Perit Dial Int 2007;27:S228-S232.
43.
Agostoni PG, Marenzi GC, Lauri G, Perego G, Schianni M, Sganzerla P, Guazzi MD: Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result. Am J Med 1994;96:191-199.
44.
Núñez J, González M, Miñana G, Garcia-Ramón R, Sanchis J, Bodí V, Núñez E, Puchades MJ, Palau P, Merlos P, Llàcer A, Miguel A: Continuous ambulatory peritoneal dialysis as a therapeutic alternative in patients with advanced congestive heart failure. Eur J Heart Fail 2012;14:540-548.
45.
Courivaud C, Kazory A, Crépin T, Azar R, Bresson-Vautrin C, Chalopin JM, Ducloux D: Peritoneal dialysis reduces the number of hospitalization days in heart failure patients refractory to diuretics. Perit Dial Int 2014;34:100-108.
46.
Koch M, Haastert B, Kohnle M, Rump LC, Kelm M, Trapp R, Aker S: Peritoneal dialysis relieves clinical symptoms and is well tolerated in patients with refractory heart failure and chronic kidney disease. Eur J Heart Fail 2012;14:530-539.
47.
Piraino B, Bernardini J, Brown E, Figueiredo A, Johnson DW, Lye WC, Price V, Ramalakshmi S, Szeto CC: ISPD position statement on reducing the risks of peritoneal dialysis-related infections. Perit Dial Int 2011;31:614-630.
48.
Uhlinova J, Pechter U, Kermes K, Ots-Rosenberg M: Peritoneal dialysis penetration and peritonitis rate at a single centre during last decade. Int J Nephrol 2011;2011:470426.
49.
Daly CD, Campbell MK, MacLeod AM, Cody DJ, Vale LD, Grant AM, Donaldson C, Wallace SA, Lawrence PD, Khan IH: Do the Y-set and double-bag systems reduce the incidence of peritonitis? A systematic review of randomized controlled trials. Nephrol Dial Transplant 2001;16:341-347.
50.
Remón-Rodríguez C, Quirós-Ganga P, Portolés-Pérez J, Gómez-Roldán C, Miguel-Carrasco A, Borràs-Sans M, Rodríguez-Carmona A, Pérez-Fontán M, Sánchez-Álvarez JE, Rodríguez Suárez C; Grupo Cooperativo Registros Españoles de Diálisis Peritoneal: Results of the cooperative study of Spanish peritoneal dialysis registries: analysis of 12 years of follow-up. Nefrologia 2014;34:18-33.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.